Fungal Infection Testing + Diagnostics for Human Health

Since 2002, MiraVista Diagnostics has been developing and evolving our menu of diagnostic tests for fungal infections. We work with hospital labs, research university labs, government and municipal labs, physician practices, large reference labs and CROs across the country to detect, analyze and monitor a wide range of serious mycology infections that afflict their patients. This includes antigen and antibody detection tests for aspergillus, blastomyces dermatitidis, histoplasma capsulatum, coccidioides, cryptococcus and beta-D-glucan.

Accurate Test Results Lead to Better Patient Outcomes

MiraVista Diagnostics understands the critical role we play in the health care and health science continuum. Because we take that responsibility seriously, we are committed to partnering with clinicians to consistently deliver:

  • Superior clinical standards in testing accuracy and sensitivity
  • Rapid response and test results
  • Dedication to excellent client service and customer satisfaction
  • Direct access to our infectious disease experts
  • Quality assurance across our organization
  • Compliance with regulatory mandates and industry best practices
  • Continuous product and service improvement
Company News

ALERT: Extreme Winter Weather May Delay Shipments to MiraVista’s Lab

Extreme winter weather conditions across the country could impact deliveries to MiraVista Diagnostics lab in Indianapolis, Indiana. Please check directly with your shipping carrier for alerts about weather-related service interruptions or delays that could impact your shipments to our lab….
READ MORE →

Happy New Year From Everyone at MiraVista Diagnostics

Everyone at MiraVista Diagnostics wishes you a Happy New Year!  We hope you had a wonderful holiday season and you’re just as excited to kick off 2019 as we are. HAPPY NEW YEAR MiraVista Diagnostics has an incredible team of…
READ MORE →

NIH Approved Institutional Biosafety Committee (IBC) Meeting Scheduled for January 14

In compliance with the National Institutes of Health Office of Science Policy (NIH OSP), MiraVista Diagnostics LLC has formed an Institutional Biosafety Committee (IBC) to review, approve and confirm that the company’s research involving recombinant/synthetic DNA complies with NIH guidelines….
READ MORE →

CDC Investigating Histoplasmosis Outbreak Among Boy Scout Campers in Baton Rouge

At least two Boy Scout campers have been diagnosed with histoplasmosis after staying at Camp Avondale in Baton Rouge, Louisiana.

MiraVista to Receive Economic Incentives from IEDC for Expansion Efforts

Indiana Economic Development Corporation Offers economic incentives to MiraVista Diagnostics. This includes $275,000 in tax credits and $50,000 in training grants to hire additional employees and expand its corporate headquarters and diagnostic laboratory in Indianapolis.

MiraVista Diagnostics is Participating in 2018 ID Week in San Francisco

MiraVista Diagnostics is participating in 2018 ID Week in San Francisco on October 3-7, 2018. Visit us at booth #1032. Representatives from MiraVista will be available to discuss our latest mycology research and menu of diagnostic tests for serious fungal…
READ MORE →

ORDER TESTS
  • vendor logo
  • vendor logo
  • vendor logo
  • vendor logo
  • vendor logo